Page last updated: 2024-09-05

sorafenib and galactose

sorafenib has been researched along with galactose in 5 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(galactose)
Trials
(galactose)
Recent Studies (post-2010) (galactose)
6,5207305,25118,9881934,605

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Dykens, JA; Hirakawa, B; Hynes, J; Jamieson, J; Jessen, BA; Marroquin, LD; Nadanaciva, S; Patyna, S; Will, Y1
Bondì, ML; Cavallaro, G; Craparo, EF; Giammona, G; Sardo, C; Serio, R; Zizzo, MG1
Bhargava, S; Kulhari, H; Kuncha, M; Pooja, D; Sistla, R; Tunki, L; Vadithe, LN1
Alés, E; Castillejos, MC; Cepeda-Franco, C; de la Cruz-Ojeda, P; Flores, JA; Gutiérrez-Valencia, A; Khiar, N; Mena-Barragán, T; Muntané, J; Navarro-Villarán, E; Negrete, M; Romero-Ben, E; Rosales-Barrios, C1
Chaudhari, P; Darshan, K; Dhawan, V; Joshi, G; Lokras, A; Marwah, M; Mohanty, B; Nagarsenker, M; Saraf, M; Venkatraman, M; Warawdekar, U1

Other Studies

5 other study(ies) available for sorafenib and galactose

ArticleYear
Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells.
    Toxicological sciences : an official journal of the Society of Toxicology, 2008, Volume: 106, Issue:1

    Topics: Adenosine Triphosphate; Animals; Benzamides; Benzenesulfonates; Cell Survival; Dasatinib; Dose-Response Relationship, Drug; Electron Transport; Galactose; Glucose; Imatinib Mesylate; Indoles; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocytes, Cardiac; Niacinamide; Oxidative Phosphorylation; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Sorafenib; Sunitinib; Thiazoles

2008
Galactosylated polymeric carriers for liver targeting of sorafenib.
    International journal of pharmaceutics, 2014, May-15, Volume: 466, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Biological Availability; Drug Carriers; Ethylenediamines; Female; Galactose; Kidney; Liver; Lung; Mice, Inbred C57BL; Micelles; Niacinamide; Peptides; Phenylurea Compounds; Polyesters; Sorafenib; Spleen

2014
Modulating the site-specific oral delivery of sorafenib using sugar-grafted nanoparticles for hepatocellular carcinoma treatment.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2019, Sep-01, Volume: 137

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Drug Liberation; Galactose; Hep G2 Cells; Humans; Lipids; Liver Neoplasms; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Nanoparticles; Polyethylene Glycols; Sorafenib; Tissue Distribution

2019
PDA-Based Glyconanomicelles for Hepatocellular Carcinoma Cells Active Targeting Via Mannose and Asialoglycoprotein Receptors.
    ACS applied bio materials, 2021, 06-21, Volume: 4, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Proliferation; Endosomes; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Mannose; Mannose Receptor; Micelles; Nanoparticles; Polyacetylene Polymer; Sorafenib

2021
Polysaccharide and monosaccharide guided liver delivery of Sorafenib Tosylate - A nano-strategic approach and comparative assessment of hepatospecificity.
    International journal of pharmaceutics, 2022, Sep-25, Volume: 625

    Topics: Drug Delivery Systems; Galactose; Ligands; Liposomes; Liver; Monosaccharides; Particle Size; Polysaccharides; Sepharose; Sorafenib; Tissue Distribution

2022